MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Vaccine Development & Manufacturing
TapImmune (NASDAQ:TPIV)
Attachments
TapImmune – An immuno-oncology company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease.
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Breast
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Ovarian
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Vaccines
*Architects: Vaccine Development & Manufacturing
*Industry: Seattle
*Industry: Washington
Children
2010: Mayo Clinic to license vaccine technology to Seattle startup « MedCity News
Founded 1999
Seattle, Washington
T-cell vaccine candidate TPIV2000 in patients with ovarian and breast cancer.
TapImmune Inc Stock Quote: TPIV Stock News, Quotes, Analysis
Jumps
Mayo Clinic Health System (Rochester, Minn.): 16 hospitals-#2-US News _ (Cancer Center-US New & World Report)
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)*